Skip to main content
Print Save

MYLAN FE 134 MYLAN FE 134 (Fenofibrate (Micronized) 134 mg)

Pill with imprint MYLAN FE 134 MYLAN FE 134 is Orange & White, Capsule-shape and has been identified as Fenofibrate (Micronized) 134 mg. It is supplied by Mylan Pharmaceuticals Inc.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iib, elevated ldl vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 134 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN FE 134 MYLAN FE 134

Fenofibrate (micronized) 134 mg MYLAN FE 134 MYLAN FE 134
Fenofibrate (micronized) 134 mg MYLAN FE 134 MYLAN FE 134
Fenofibrate (micronized) 134 mg MYLAN FE 134 MYLAN FE 134

Fenofibrate (Micronized)

Imprint
MYLAN FE 134 MYLAN FE 134
Strength
134 mg
Color
Orange & White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-8629 (Discontinued)
Inactive Ingredients
silicon dioxide, corn starch, croscarmellose sodium, D&C Yellow No. 10, FD&C Yellow No. 6, lactose monohydrate, magnesium stearate, sodium lauryl sulfate, titanium dioxide, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, ammonia

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer